Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide and tirzepatide drive significant weight loss by reducing appetite and slowing gastric emptying, with clinical trials showing 15-22% body weight reduction over 68 weeks. However, rapid weight loss can include loss of lean muscle tissue unless you implement targeted resistance training and adequate protein consumption. Understanding the relationship between GLP-1 therapy and muscle development helps you achieve body composition goals, not just scale weight reduction.
How GLP-1 Medications Affect Muscle Tissue
GLP-1 agonists work by activating receptors in the brain that regulate hunger and satiety, causing you to eat less food overall. This calorie deficit is essential for weight loss, but the body will break down muscle for energy if protein intake falls too low. Studies show that without adequate resistance exercise and protein, approximately 25-30% of weight lost on GLP-1 therapy can come from lean muscle rather than fat.
The medications themselves do not directly cause muscle loss—the deficit does. Your basal metabolic rate (the calories your body burns at rest) depends partly on muscle mass, so losing muscle during treatment makes it harder to maintain weight loss long-term. PlexusDx recognizes this risk and emphasizes that GLP-1 success depends on lifestyle decisions you make during treatment, not just the medication dose.
Resistance Training and Protein Intake During GLP-1 Therapy
Building or preserving muscle on GLP-1 requires two non-negotiable inputs: progressive resistance training (3-4 sessions per week) and 1.6-2.2 grams of protein per kilogram of body weight daily. Strength training sends a signal to your muscles to adapt and grow, counteracting the catabolic (muscle-breaking-down) effect of calorie restriction. Research in the International Journal of Obesity found that participants who combined resistance exercise with GLP-1 therapy lost significantly more fat and retained more lean mass than those who relied on medication alone.
Protein synthesis—the process your body uses to build new muscle—requires adequate amino acid availability. When you take semaglutide or tirzepatide, appetite suppression can make hitting high protein targets feel challenging. Planning small, protein-dense meals throughout the day (cottage cheese, Greek yogurt, eggs, fish, tofu) and considering protein supplements helps you reach your target without relying on large portions.
Genetic Factors in Muscle Response to GLP-1 Treatment
Individual variation in how your body responds to GLP-1 therapy partly reflects genetic differences in appetite regulation and energy metabolism. The PlexusDx Precision Peptide Genetic Test identifies variants in pathways controlling peptide signaling, including the GLP1R rs6923761 variant and MC4R rs17782313, which influence your baseline metabolic rate and how aggressively GLP-1 suppresses hunger.
Knowing your genetic profile helps PlexusDx clinicians personalize your treatment approach—for example, individuals with certain GLP1R variants may need higher protein targets or more frequent resistance sessions to offset greater appetite suppression. The test costs $99 as an add-on after your first month of treatment and maps 49 peptides across 14 metabolic pathways, giving you data-driven insight into your unique physiology. This personalized framework replaces one-size-fits-all recommendations with a precision approach to muscle preservation.
Can You Build New Muscle (Hypertrophy) on GLP-1?
Building significant new muscle while in a calorie deficit is difficult but possible in specific populations. Individuals new to strength training, those returning after a long break, and people with high body fat percentages can experience 'newbie gains'—simultaneous fat loss and muscle gain—during the first 8-12 weeks of GLP-1 therapy combined with resistance training. This phenomenon occurs because untrained muscles respond aggressively to stimulus, and the calorie deficit fuels fat oxidation while protein and training drive muscle protein synthesis.
For individuals already lean or advanced in training, the realistic goal during GLP-1 therapy is muscle preservation rather than growth. Prioritize maintaining your strength levels (lifting the same weights or slightly higher) and body composition metrics (DEXA scan or bioelectrical impedance analysis) rather than expecting bicep growth. Once you reach your target weight on semaglutide or tirzepatide, you can transition to a slight calorie surplus to support true hypertrophy while continuing GLP-1 at a maintenance dose.
Optimizing Your Body Composition on PlexusDx GLP-1 Protocol
PlexusDx offers compounded semaglutide injection starting at $149 per month, delivered to all 50 states without insurance requirements. Your dose increases based on clinical response and tolerance, but PlexusDx's pricing structure ensures your cost stays flat—the marketing principle is 'your dose may need to go up, your price won't.' This allows you to scale medication safely without financial surprises, making it easier to sustain the consistency needed for successful body composition change.
Success on PlexusDx combines medication with a structured fitness plan: resistance train 3-4 times weekly, consume 1.6-2.2 g protein per kg body weight, prioritize sleep (7-9 hours nightly to support muscle recovery), and track your progress using body composition metrics rather than weight alone. PlexusDx clinicians can review your training approach and adjust your GLP-1 therapy if needed. The Precision Peptide Genetic Test ($99 add-on) provides additional insights into your individual peptide pathways, ensuring your protocol matches your genetics.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose muscle if I start semaglutide or tirzepatide?
Muscle loss is not automatic, but risk exists if you combine GLP-1 therapy with low protein intake and no resistance training. Studies show 25-30% of weight loss can be lean tissue without mitigation strategies. PlexusDx emphasizes that hitting 1.6-2.2 g protein per kg body weight and performing 3-4 resistance sessions weekly preserves and builds muscle during treatment.
How much protein should I eat on GLP-1 medication?
Aim for 1.6-2.2 grams of protein per kilogram of your body weight daily. For a 100 kg (220 lb) person, that's 160-220 g daily. GLP-1 appetite suppression makes this challenging, so meal planning and protein supplements (shakes, bars, Greek yogurt) become critical tools rather than optional extras.
What does PlexusDx Semaglutide Injection cost, and does price change with dose increases?
PlexusDx compounded semaglutide injection starts at $149 per month and remains flat regardless of dose escalation. Your medication is sourced from licensed 503A compounding pharmacies, delivered to all 50 states, and HSA/FSA eligible—no membership or insurance required. PlexusDx's pricing model ensures affordability as your dose adjusts.
Is it safe to lift heavy weights while on GLP-1 therapy?
Yes, resistance training is not only safe but essential during GLP-1 therapy to preserve lean mass. Progressive strength training signals your muscles to maintain and adapt, counteracting the catabolic effect of calorie deficit. Ensure adequate hydration, protein intake, and recovery sleep to support your training.
How does the PlexusDx Precision Peptide Genetic Test help with muscle development on GLP-1?
The test ($99 add-on after month one) identifies your genetic variants in GLP1R and MC4R pathways, which influence appetite suppression intensity and metabolic rate. This data helps PlexusDx clinicians personalize your protein targets, training frequency, and medication dosing. Understanding your genetic predisposition to certain metabolic responses replaces guesswork with precision.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Stimulates GLP-1 Production: A Deep Dive into Natural Boosters
How Long After Injecting Ozempic Does It Start Working?